Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 15, 2023 Filed Dec 15, 2023 22:22 UTC
Chopra DaveenCVP, TMTT
SaleCommon Stock 7,000 $78.25 $547,724.10
Disclosure

SEC source: 0001225208-23-011152 · doc4.xml · nonDerivative · entry 2

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,950

F1 · price: This transaction was executed in multiple trades at prices ranging from $78.24 to $78.25. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 15, 2023 Filed Dec 15, 2023 22:22 UTC
Chopra DaveenCVP, TMTT
Exercise / conversionCommon Stock 7,000 $59.26 $414,796.90
Disclosure

SEC source: 0001225208-23-011152 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 8,000 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-011074 · doc4.xml · derivative · entry 5

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Common Stock · 8,000 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 8,000 $71.86 $574,880.00
Disclosure

SEC source: 0001225208-23-011074 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,502.6931

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 8,000 $36.75 $294,000.00
Disclosure

SEC source: 0001225208-23-011074 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,502.6931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 8,658 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001225208-23-011073 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,658 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 8,658 $71.86 $622,163.88
Disclosure

SEC source: 0001225208-23-011073 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionCommon Stock 8,658 $45.28 $392,005.67
Disclosure

SEC source: 0001225208-23-011073 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,451.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,350 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · derivative · entry 7

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 146,750

Underlying: Common Stock · 29,350 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC SaleCommon Stock 13,722 $75.12 $1,030,796.64
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,485.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F5 · price: This transaction was executed in multiple trades at prices ranging from $74.530 to $75.510. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC SaleCommon Stock 10,600 $74.22 $786,732.00
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,207.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F4 · price: This transaction was executed in multiple trades at prices ranging from $73.520 to $74.515. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC SaleCommon Stock 3,200 $73.15 $234,080.00
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 28,807.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $72.510 to $73.510. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC SaleCommon Stock 1,828 $75.73 $138,434.44
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,007.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $75.560 to $75.970. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 13, 2023 Filed Dec 14, 2023 00:04 UTC Exercise / conversionCommon Stock 29,350 $36.75 $1,078,612.50
Disclosure

SEC source: 0001225208-23-011072 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,835.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

Read SEC document
December 06, 2023 Filed Dec 6, 2023 22:01 UTC
Chopra DaveenCVP, TMTT
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 3,500 $0.00 Strike: $59.26 $0.00
Disclosure

SEC source: 0001225208-23-010794 · doc4.xml · derivative · entry 3

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,000

Underlying: Common Stock · 3,500 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2023 Filed Dec 6, 2023 22:01 UTC
Chopra DaveenCVP, TMTT
SaleCommon Stock 3,500 $70.00 $245,005.60
Disclosure

SEC source: 0001225208-23-010794 · doc4.xml · nonDerivative · entry 2

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,950

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $70.00 to $70.01. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 06, 2023 Filed Dec 6, 2023 22:01 UTC
Chopra DaveenCVP, TMTT
Exercise / conversionCommon Stock 3,500 $59.26 $207,398.45
Disclosure

SEC source: 0001225208-23-010794 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 8,660 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001225208-23-010211 · doc4.xml · derivative · entry 6

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,658

Underlying: Common Stock · 8,660 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 5,402 $65.64 $354,565.13
Disclosure

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $65.21 to $66.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 3,158 $64.68 $204,273.65
Disclosure

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,195.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $64.20 to $65.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 100 $66.21 $6,621.00
Disclosure

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,353.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionCommon Stock 8,660 $45.28 $392,096.22
Disclosure

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,453.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 6,000 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-010210 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Common Stock · 6,000 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 3,700 $65.66 $242,929.05
Disclosure

SEC source: 0001225208-23-010210 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,502.6931

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $65.28 to $66.12. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 2,300 $64.72 $148,851.17
Disclosure

SEC source: 0001225208-23-010210 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,202.6931

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $64.28 to $65.21. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 13, 2023 Filed Nov 13, 2023 22:21 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 6,000 $36.75 $220,500.00
Disclosure

SEC source: 0001225208-23-010210 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,502.6931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

Read SEC document
November 06, 2023 Filed Nov 6, 2023 23:33 UTC GiftCommon Stock 371,689 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010019 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · By Living Trust

Disclosed balance after: 4,038,377

F3 · acquired: In connection with an in-kind transfer of shares from the Reporting Person's 401(k) account to his Living Trust, the remaining 0.7321 of one share was automatically sold by the 401(k) plan administrator at a price of $63.505269 per share, for a total of $46.50, to comply with the plan administrator's policy prohibiting the transfer of a fractional share.

Read SEC document
November 06, 2023 Filed Nov 6, 2023 23:33 UTC GiftCommon Stock 371,689 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-010019 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · 401(k)

Disclosed balance after: 0

F3 · acquired: In connection with an in-kind transfer of shares from the Reporting Person's 401(k) account to his Living Trust, the remaining 0.7321 of one share was automatically sold by the 401(k) plan administrator at a price of $63.505269 per share, for a total of $46.50, to comply with the plan administrator's policy prohibiting the transfer of a fractional share.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 23:33 UTC Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,350 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-010019 · doc4.xml · derivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,100

Underlying: Common Stock · 29,350 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 23:33 UTC SaleCommon Stock 29,350 $67.18 $1,971,733.00
Disclosure

SEC source: 0001225208-23-010019 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,485.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $66.59 to $67.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 03, 2023 Filed Nov 6, 2023 23:33 UTC Exercise / conversionCommon Stock 29,350 $36.75 $1,078,612.50
Disclosure

SEC source: 0001225208-23-010019 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,835.82

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

Read SEC document
October 31, 2023 Filed Oct 31, 2023 21:22 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 7,255 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-009845 · doc4.xml · derivative · entry 4

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 43,525

Underlying: Common Stock · 7,255 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 31, 2023 Filed Oct 31, 2023 21:22 UTC
Ullem Scott B.CVP, Chief Financial Officer
SaleCommon Stock 7,255 $62.66 $454,568.55
Disclosure

SEC source: 0001225208-23-009845 · doc4.xml · nonDerivative · entry 2

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,248

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $62.40 to $63.03. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 31, 2023 Filed Oct 31, 2023 21:22 UTC
Ullem Scott B.CVP, Chief Financial Officer
Exercise / conversionCommon Stock 7,255 $36.75 $266,621.25
Disclosure

SEC source: 0001225208-23-009845 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,503

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 5, 2023.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:02 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 8,660 $0.00 Strike: $45.28 $0.00
Disclosure

SEC source: 0001225208-23-009479 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,318

Underlying: Common Stock · 8,660 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:02 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 5,150 $70.26 $361,863.72
Disclosure

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.05 to $70.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:02 UTC
Wood Larry LGlobal President TAVR & Surg
SaleCommon Stock 3,510 $69.61 $244,334.26
Disclosure

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,943.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $69.05 to $70.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:02 UTC
Wood Larry LGlobal President TAVR & Surg
Exercise / conversionCommon Stock 8,660 $45.28 $392,096.22
Disclosure

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,453.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:01 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 5,000 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-009478 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 5,000 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:01 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 3,000 $70.25 $210,753.60
Disclosure

SEC source: 0001225208-23-009478 · doc4.xml · nonDerivative · entry 3

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,502.6931

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.05 to $70.45. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:01 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 2,000 $69.58 $139,155.60
Disclosure

SEC source: 0001225208-23-009478 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,502.6931

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $69.05 to $69.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
October 13, 2023 Filed Oct 13, 2023 21:01 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 5,000 $36.75 $183,750.00
Disclosure

SEC source: 0001225208-23-009478 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,502.6931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 2, 2023.

Read SEC document
October 10, 2023 Filed Oct 10, 2023 22:23 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 5,000 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-009461 · doc4.xml · derivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,000

Underlying: Common Stock · 5,000 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 10, 2023 Filed Oct 10, 2023 22:23 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 5,000 $72.68 $363,400.00
Disclosure

SEC source: 0001225208-23-009461 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 34,813.571

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023.

Read SEC document
October 10, 2023 Filed Oct 10, 2023 22:23 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 5,000 $36.75 $183,750.00
Disclosure

SEC source: 0001225208-23-009461 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,813.571

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 6, 2023.

Read SEC document
October 03, 2023 Filed Oct 3, 2023 20:58 UTC
Chopra DaveenCVP, TMTT
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 8,500 $0.00 Strike: $59.26 $0.00
Disclosure

SEC source: 0001225208-23-009259 · doc4.xml · derivative · entry 3

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,500

Underlying: Common Stock · 8,500 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 03, 2023 Filed Oct 3, 2023 20:58 UTC
Chopra DaveenCVP, TMTT
SaleCommon Stock 8,500 $70.00 $595,000.00
Disclosure

SEC source: 0001225208-23-009259 · doc4.xml · nonDerivative · entry 2

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 23,950

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.

Read SEC document
October 03, 2023 Filed Oct 3, 2023 20:58 UTC
Chopra DaveenCVP, TMTT
Exercise / conversionCommon Stock 8,500 $59.26 $503,681.95
Disclosure

SEC source: 0001225208-23-009259 · doc4.xml · nonDerivative · entry 1

Chopra Daveen · CIK 0001740963 · CVP, TMTT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,450

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2023.

Read SEC document
October 02, 2023 Filed Oct 2, 2023 22:51 UTC Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 29,350 $0.00 Strike: $36.75 $0.00
Disclosure

SEC source: 0001225208-23-009136 · doc4.xml · derivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,450

Underlying: Common Stock · 29,350 shares

Expires 2024-05-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 02, 2023 Filed Oct 2, 2023 22:51 UTC SaleCommon Stock 29,350 $68.84 $2,020,454.00
Disclosure

SEC source: 0001225208-23-009136 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,485.82

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 15, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $68.39 to $69.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.